Prostate motion during standard radiotherapy as assessed by fiducial markers
- 1 October 1995
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 37 (1) , 35-42
- https://doi.org/10.1016/0167-8140(95)01613-l
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Measurement of prostate movement over the course of routine radiotherapy using implanted markersInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Preliminary results of a hyperfractionated dose escalation study for locally advanced adenocarcinoma of the prostateRadiotherapy and Oncology, 1993
- The retrograde urethrogram is more accurate than ct in identifying the caudal prostate margin for conformal treatment planningInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Conformal radiation in prostate cancer: Reduced morbidity with hope of increased local controlInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Evaluation of changes in the location and shape of the prostate and rectum during a seven week course of conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The effect of dose on local control of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988